Lighthouse Pharma
lighthousepharma.com
Actively hiring
Biologics & Biosimilars
Precision Medicine
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Lighthouse Pharma is a clinical stage private biopharmaceutical company pioneering precision medicine approaches to major unmet medical needs. Lighthouse’s lead program, LHP588, is in Phase 2 clinical for P. gingivalis-positive Alzheimer.
News
Lighthouse Pharma receives $49.2 million grant from NIA to advance phase 2 study of LHP588 for P. gingivalis-positive Alzheimer's disease
Lighthouse Pharma receives $49.2 million grant from NIA to advance phase 2 study of LHP588 for P. gingivalis-positive Alzheimer
Read more
Report